Our study found that knockdown of ADORA2A-AS1 decreased the expression of TGFBR1 by releasing miR-665, which explains reduced proliferation in CML cells after ADORA2A-AS1 knockdown. The gene discussed is ADORA2A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.